The hair restoration market (including oral medications, laser treatments, and hair-growth shampoos) reached a staggering $8.77 billion globally in 2023, according to market research company Grand ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...